Sartorius Stedim Biotech SA DIM

Stock XPAR Rating as of Nov 10, 2026

€226.80 +3.40 (1.52%)

As of Nov 11, 2026, 4:35:16 PM Delayed Price Closed

Company Report

Sartorius Stedim Earnings: Consumables Underpins Revenue Growth; Shares Are Fairly Valued

Matthew Donen Oct 22, 2026

Sartorius Stedim grew third-quarter sales 7.4% in constant currencies before tariff compensation to customers. Underlying EBITDA margin was 31.1% versus 31.3% a year earlier, which was in line with company-compiled consensus. Management confirmed full-year guidance.

Read Analysis

Price vs Fair Value

View History

DIM is trading at a LOCK|$>dJW? premium.

Price

€223.40

Nov 10, 2026

Fair Value

jHy

May 7, 2025

Uncertainty

LOCK|Qh

1-Star Price: LOCK|>.F
5-Star Price: LOCK|$.%l
Economic Moat: LOCK|>^<
Capital Allocation: LOCK|T^#l&c?

Bulls Say, Bears Say

Bulls

SSB's CGT product portfolio allows the company to capitalize on long-term growth, should these therapies achieve widespread adoption.

Bears

The high growth in the biopharma market increases the risk of greater competition from better-capitalized peers that have a broader product offering.

Trading Information

Previous Close Price: €223.40
Day Range: €222.00–226.80
52-Week Range: €150.00–229.80
Bid/Ask: €223.60 / €227.00
Shares Outstanding: 97.31M
Market Cap: €22.07B
Volume/Avg: 71,742 / 92,062

Key Statistics

Price/Earnings (Normalized): 50.35
Price/Sales: 7.10
Dividend Yield (Trailing): 0.31%
Dividend Yield (Forward): 0.31%
Dividend Payment Schedule: Apr
Total Yield: 0.31%

Company Profile

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Stock Style Box: Mid Growth
Total Number of Employees: 10,483
Website: https://www.sartorius.com

Competitors

Valuation

Metric	DIM	TMO	MRK
Price/Earnings (Normalized)	50.35	29.05	18.51
Price/Book Value	4.96	4.86	2.15
Price/Sales	7.10	5.67	3.07
Price/Cash Flow	33.58	25.75	14.27

Price/Earnings

DIM

TMO

MRK

Financial Strength

Metric	DIM	TMO	MRK
Quick Ratio	0.50	1.23	0.99
Current Ratio	1.22	1.81	1.69
Interest Coverage	5.30	5.52	7.22

Quick Ratio

DIM

TMO

MRK

Profitability

Metric	DIM	TMO	MRK
Return on Assets (Normalized)	5.74%	8.32%	4.75%
Return on Equity (Normalized)	11.02%	17.48%	8.32%
Return on Invested Capital (Normalized)	7.90%	10.45%	6.65%

Return on Assets

DIM

TMO

MRK

Medical Instruments & Supplies Industry Comparables

Screen With Investor

Name	Capital Allocation	Economic Moat	Market Cap
Intuitive Surgical Inc ISRG	LOCK\|!M$<<SkP	LOCK\|^V	$156B
Becton Dickinson & Co BDX	LOCK\|P^	LOCK\|l?h!j	$58B
Alcon Inc ALC	LOCK\|Kjg&!@	LOCK\|!W?rd	$36B
Medline Inc Ordinary Shares - Class A MDLN	LOCK\|PyWk$D	LOCK\|!LrW$	$36B
ResMed Inc RMD	LOCK\|>&FK@fsC	LOCK\|x%#@	$33B
West Pharmaceutical Services Inc WST	LOCK\|@k^MM@!	LOCK\|@v	$29B
Solventum Corp SOLV	LOCK\|v?Lkcp?	LOCK\|w$@	$15B
Baxter International Inc BAX	LOCK\|zp!	LOCK\|%S<sn	$14B
Align Technology Inc ALGN	LOCK\|>W#%&d	LOCK\|Jfq<S	$12B
The Cooper Companies Inc COO	LOCK\|qsD$<j?	LOCK\|sCv<	$12B